VCYT

Bullish

Veracyte (VCYT) Is Up 23.8% After Raising 2026 Guidance And Expanding Decipher Cancer Studies

Veracyte (VCYT) reported strong first-quarter 2026 results, with revenue and net income exceeding expectations, leading to a 23.8% stock increase and ...

Simply Wall Street 2 weeks ago 0

Bullish

Veracyte Announces First Quarter 2026 Financial Results

Veracyte Inc. announced strong financial results for the first quarter of 2026, with total revenue increasing by 21% to $139.1 million and testing rev...

BioSpace 2 weeks ago 0